High baseline soluble urokinase plasminogen activator receptor (suPAR) serum levels indicate adverse outcome after resection of pancreatic adenocarcinoma
Sven H. Loosen(Düsseldorf University Hospital), Tom Luedde(Düsseldorf University Hospital), Patrick H. Alizai(RWTH Aachen University), Niklas Püthe, Thomas Ritz, Thomas Longerich(Heidelberg University), Georg Wiltberger(University Hospital Leipzig), Marcel Binneboesel(Klinikum Bielefeld), Christian Trautwein(TUM Klinikum), Pia Paffenholz(University Hospital Cologne), Jakob Nikolas Kather(Heidelberg University), Alexander Koch(RWTH Aachen University), Frank Tacke(Charité - Universitätsmedizin Berlin), Ulf P. Neumann(RWTH Aachen University), Christoph Roderburg(Universitätsklinikum Aachen), Frank Bergmann(Heidelberg University)
Cited by 28
Related Papers
EASL–EASD–EASO Clinical Practice Guidelines on the management of metabolic dysfunction-associated steatotic liver disease (MASLD)
|Journal of Hepatology|2024|1.6k
Senescence surveillance of pre-malignant hepatocytes limits liver cancer development
|Nature|2011|1.6k
Deep learning can predict microsatellite instability directly from histology in gastrointestinal cancer
|Nature Medicine|2019|1.5k
NF-κB in the liver—linking injury, fibrosis and hepatocellular carcinoma
|Nature Reviews Gastroenterology & Hepatology|2011|1.4k